Symposium:
213. Tuberculosis: Diagnosis and Management in the Era of XDR and HAART
Saturday, October 29, 2016: 10:30 AM-12:00 PM
Room: 293-296

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss treatment of TB in the XDR and MDR era
  • explain the complexities of treatment of TB with HAART
  • describe the promise of host-directed TB therapy and the progress in the rapid diagnosis of tuberculosis

Target Audience: Clinicians, Fellows, Healthcare workers, HIV clinicians, HIV specialists, Infectious diseases pediatricians, Infectious diseases physicians, Lab personnel, Members-in-training, Microbiologists, Nurses, Pharmacists, Public health practitioners

Tracks: Adult ID, Global ID, HIV-STD-TB, Pediatric ID

Moderators:  Wesley Van Voorhis, MD, PhD, FIDSA, University of Washington and Christina Coyle, MD, Albert Einstein College of Medicine

Presentations:
10:30 AM
Breakthroughs in TB Diagnostic Biomarkers
Jerrold Ellner, MD, FIDSA

10:55 AM
Q&A
11:00 AM
11:25 AM
Q&A
11:30 AM
11:55 AM
Q&A

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours 0.15 of pharmacy CE

ACPE Number: 0221-9999-16-288-L01-P

Disclosures:

W. Van Voorhis, None

C. Coyle, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.